Indian shares end flat as financials offset declines in pharma, IT
Feb 19 (Reuters) – India’s benchmark indexes ended flat on Wednesday as gains in heavyweight financials countered losses in pharma and IT stocks on concerns that President Donald Trump would impose more tariffs on U.S. imports. The Nifty 50 ended the day 0.05% lower at 22,932.9, while the BSE Sensex fell 0.04% to 75,939.18. On Tuesday, Trump said that he intends to levy auto tariffs “in the neighbourhood of 25%” and similar duties on semiconductors and pharmaceutical imports. This resulted in Indian pharma stocks falling 0.7% as the U.S. accounts for nearly 31% of total domestic pharma exports. Renewed concerns